Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t(6;11) translocation.

作者: Kentaro Inamura , Mutsunori Fujiwara , Yuki Togashi , Kimie Nomura , Hiroyuki Mukai

DOI: 10.1097/PAS.0B013E3182293EC3

关键词: ImmunohistochemistryMetastasisBiologyRenal cell carcinoma with t(6;11) translocationExonCarcinomaPathologyRenal cell carcinomaChromosomal translocationTFEB

摘要: Renal cell carcinoma (RCC) with t(6;11) translocation, involving the transcription factor EB (TFEB) and Alpha, also known as MALATI, (TFEB RCC), is extremely rare, only 20 cases reported to date. It may be frequently misdiagnosed because of a lack established characteristics. TFEB RCCs are predominantly seen in younger patients generally indolent, 2 metastasis. Genetic analysis has been limited, showing break points upstream exon 3, yielding single transcript. We examined 3 new adult Japanese RCC by means precise clinicopathologic, immunohistochemical, cytogenetic, molecular analyses compared them 200 ordinary RCCs. A 57-year-old man was oldest patient at time this study. Although tumor had histology typical translocation RCC, its fusion were different between genomic transcript coordinates. 37-year-old an aggressive course resulting death. The variants messenger ribonucleic acid. 47-year-old showed borderline histologic immunohistochemical features chromophobe-type RCC. point 4, downstream wild-type ATG 3. Nuclear expression protein detected, Western blotting identified similar size protein. Immunohistochemistry useful for diagnosis these tumors, have heterogeneous clinicopathologic more diverse patterns than previously thought, requiring attention polymerase chain reaction experiments diagnosis. Our study will contribute correct

参考文章(13)
Philippe Camparo, Viorel Vasiliu, Vincent Molinie, Jerome Couturier, Karl J. Dykema, David Petillo, Kyle A. Furge, Eva M. Comperat, Marick Lae, Raymonde Bouvier, Liliane Boccon-Gibod, Yves Denoux, Sophie Ferlicot, Eric Forest, Gaelle Fromont, Marie C. Hintzy, Myriam Laghouati, Mathilde Sibony, Marie L. Tucker, Nina Weber, Bin T. Teh, Annick Vieillefond, Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. The American Journal of Surgical Pathology. ,vol. 32, pp. 656- 670 ,(2008) , 10.1097/PAS.0B013E3181609914
James I. Geller, Pedram Argani, Adebowale Adeniran, Edith Hampton, Angelo De Marzo, Jessica Hicks, Margaret H. Collins, Translocation renal cell carcinoma: lack of negative impact due to lymph node spread. Cancer. ,vol. 112, pp. 1607- 1616 ,(2008) , 10.1002/CNCR.23331
G Martignoni, M Pea, S Gobbo, M Brunelli, F Bonetti, D Segala, Chin-Chen Pan, G Netto, C Doglioni, O Hes, P Argani, M Chilosi, Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Modern Pathology. ,vol. 22, pp. 1016- 1022 ,(2009) , 10.1038/MODPATHOL.2009.58
He-Qin Zhan, Chao-Fu Wang, Xiong-Zeng Zhu, Xiao-Li Xu, Renal Cell Carcinoma With t(6;11) Translocation: A Patient Case With a Novel Alpha-TFEB Fusion Point Journal of Clinical Oncology. ,vol. 28, ,(2010) , 10.1200/JCO.2010.30.3172
Milan Hora, Ondřej Hes, Tomáš Ürge, Viktor Eret, Jiří Klečka, Michal Michal, A distinctive translocation carcinoma of the kidney [“rosette-like forming,” t(6;11), HMB45-positive renal tumor] International Urology and Nephrology. ,vol. 41, pp. 553- 557 ,(2009) , 10.1007/S11255-008-9495-8
Pedram Argani, Anita Hawkins, Constance A. Griffin, Jeffrey D. Goldstein, Mark Haas, J. Bruce Beckwith, Carl B. Mankinen, Elizabeth J. Perlman, A Distinctive Pediatric Renal Neoplasm Characterized by Epithelioid Morphology, Basement Membrane Production, Focal HMB45 Immunoreactivity, and t(6;11)(p21.1;q12) Chromosome Translocation American Journal of Pathology. ,vol. 158, pp. 2089- 2096 ,(2001) , 10.1016/S0002-9440(10)64680-9
Lorenza Pecciarini, M. Giulia Cangi, Crocifissa Lo Cunsolo, Ettore Macri', Elena Dal Cin, Guido Martignoni, Claudio Doglioni, Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient. Genes, Chromosomes and Cancer. ,vol. 46, pp. 419- 426 ,(2007) , 10.1002/GCC.20422
Pedram Argani, Marick La??, Brian Hutchinson, Victor E Reuter, Margaret H Collins, John Perentesis, John E Tomaszewski, John S. J Brooks, Geza Acs, Julia A Bridge, Sara O Vargas, Ian J Davis, David E Fisher, Marc Ladanyi, Renal carcinomas with the t(6;11)(p21;q12): Clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR The American Journal of Surgical Pathology. ,vol. 29, pp. 230- 240 ,(2005) , 10.1097/01.PAS.0000146007.54092.37
Yoshinobu Komai, Mutsunori Fujiwara, Yasuhisa Fujii, Hiroyuki Mukai, Junji Yonese, Satoru Kawakami, Shinya Yamamoto, Toshiro Migita, Yuichi Ishikawa, Morito Kurata, Takuro Nakamura, Iwao Fukui, Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry. Clinical Cancer Research. ,vol. 15, pp. 1170- 1176 ,(2009) , 10.1158/1078-0432.CCR-08-1183
Roland P Kuiper, Marga Schepens, José Thijssen, Martien van Asseldonk, Eva van den Berg, Julia Bridge, Ed Schuuring, Eric FPM Schoenmakers, Ad Geurts van Kessel, Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution Human Molecular Genetics. ,vol. 12, pp. 1661- 1669 ,(2003) , 10.1093/HMG/DDG178